AJP - Heart Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 285: H145-H153, 2003. First published March 13, 2003; doi:10.1152/ajpheart.01036.2002
0363-6135/03 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
285/1/H145    most recent
01036.2002v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (16)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kirchhof, P.
Right arrow Articles by Boknik, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kirchhof, P.
Right arrow Articles by Boknik, P.

Altered sinus nodal and atrioventricular nodal function in freely moving mice overexpressing the A1 adenosine receptor

Paulus Kirchhof,1,* Larissa Fabritz,1,* Lisa Fortmüller,1 G. Paul Matherne,4 Amy Lankford,4 Hideo A. Baba,3 Wilhelm Schmitz,2 Günter Breithardt,1 Joachim Neumann,2 and Peter Boknik2

1Department of Cardiology and Angiology and 2Institute for Pharmacology and Toxicology, University Hospital Münster, D-48129 Münster; 3Institute for Pathology, University of Essen, D-45122 Essen, Germany; and 4Department of Pediatrics and Cardiovascular Research Center, University of Virginia, Charlottesville, Virginia 22908-1356

Submitted 2 December 2002 ; accepted in final form 2 February 2003


    ABSTRACT
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
To investigate whether altered function of adenosine receptors could contribute to sinus node or atrioventricular (AV) nodal dysfunction in conscious mammals, we studied transgenic (TG) mice with cardiac-specific overexpression of the A1 adenosine receptor (A1AR). A Holter ECG was recorded in seven freely moving littermate pairs of mice during normal activity, exercise (5 min of swimming), and 1 h after exercise. TG mice had lower maximal heart rates (HR) than wild-type (WT) mice (normal activity: 437 ± 18 vs. 522 ± 24 beats/min, P < 0.05; exercise: 650 ± 13 vs. 765 ± 28 beats/min, P < 0.05; 1 h after exercise: 588 ± 18 vs. 720 ± 12 beats/min, P < 0.05; all values are means ± SE). Mean HR was lower during exercise (589 ± 16 vs. 698 ± 34 beats/min, P < 0.05) and after exercise (495 ± 16 vs. 592 ± 27 beats/min, P < 0.05). Minimal HR was not different between genotypes. HR variability (SD of RR intervals) was reduced by 30% (P < 0.05) in TG compared with WT mice. Pertussis toxin (n = 4 pairs, 150 µg/kg ip) reversed bradycardia after 48 h. TG mice showed first-degree AV nodal block (PQ interval: 42 ± 2 vs. 37 ± 2 ms, P < 0.05), which was diminished but not abolished by pertussis toxin. Isolated Langendorff-perfused TG hearts developed spontaneous atrial arrhythmias (3 of 6 TG mice vs. 0 of 9 WT mice, P < 0.05). In conclusion, A1AR regulate sinus nodal and AV nodal function in the mammalian heart in vivo. Enhanced expression of A1AR causes sinus nodal and AV nodal dysfunction and supraventricular arrhythmias.

heart rate regulation; autonomous nervous system; heart rate variability; sinus node dysfunction; atrioventricular block; atrial fibrillation


SINUS NODE DYSFUNCTION is a heterogeneous disease that is clinically characterized by bradycardia, a decreased chronotropic response to exercise, and the so-called tachycardia-bradycardia syndrome, in which sinus nodal pauses are followed by atrial tachyarrhythmias and atrial fibrillation (31). Atrioventricular (AV) nodal conduction delay can be associated with the disease (31).

Familial occurrence and an autosomal dominant inheritance in some cases suggest a genetic predisposition to sinus node dysfunction (19, 24). Mutations in pacemaker channel genes (e.g., HCN2) could potentially cause sinus node dysfunction (37), but so far the etiology of the disease remains unresolved.

Under physiological conditions, heart rate is mainly determined by the depolarization rate of pacemaker cells in the sinus node (6, 32). Autonomic regulation of pacemaker activity probably alters the function of muscarinic K+ current (IK,ACh), pacemaker current, the L-type Ca2+ channel, and sustained inward current (6, 32). In addition to {beta}-adrenoreceptors and muscarinic receptors, A1 adenosine receptors (A1AR) are active in the sinus node. Short-term A1AR stimulation causes bradycardia and AV block in humans (7). Neurotransmitters and hormones like adenosine that activate IK,ACh all stimulate pertussis toxin-sensitive G proteins, resulting in the dissociation of the G protein complex in G{beta}{gamma} and GTP-bound G{alpha} subunits. Liberated G{beta}{gamma} activates IK,ACh directly by physical association (14). As adenosine is constantly present in the interstitial space (5), chronically enhanced function of A1AR could contribute to both sinus nodal and AV nodal dysfunction in vivo.

To study the physiological and pathophysiological relevance of these potential heart rate-regulatory mechanisms, we used transgenic (TG) mice overexpressing A1AR (13, 23). These mice have an increased tolerance to ischemia. Of note, A1AR overexpression slows heart rate in isolated hearts (13, 23). In this study, we describe that overexpression of A1AR decreases the physiological heart rate response to exercise in freely moving mice and slows AV nodal conduction. Furthermore, spontaneous atrial tachyarrhythmias were observed in isolated hearts from TG mice. Our data demonstrate that A1AR contribute to the physiological regulation of heart rate and AV nodal function in mice in vivo and suggest that an enhanced expression or function of A1AR may represent a potential pathomechanism by which A1AR could contribute to sinus node and AV nodal dysfunction in patients.


    METHODS
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Mice were bred from a well-characterized TG mouse line with heart-directed ({alpha}-myosin heavy chain promotor) overexpression of A1AR (23). The mice used for this study had a 200- to 300-fold overexpression of A1AR (23, 28). All measurements were performed in age- and sex-matched littermate pairs of TG and wild-type (WT) mice. The study conformed with the National Institutes of Health Guide for the Care and Use of Laboratory Animals (NIH Publication No. 85-23, Revised 1996).

Surface ECG Measurements

Mice were sedated by intraperitoneal application of a mixture of ketamine (30 mg/kg body wt) and xylazine (10 mg/kg) at 3 mo of age. The animals were placed in a recumbent position, and gel-covered silver wire loops were attached around the four limbs of the animals to record a six-lead surface ECG. The signals were preamplified and displayed on paper (amplitude 20 mA/mm, paper speed 100 mm/s, Siemens Megacart; Erlangen, Germany).

Telemetric In Vivo ECG Recordings

Three-month-old mice were instrumented with a telemetric ECG transmitter (Data Science; Minneapolis, MN) in general anesthesia (50 mg ketamine-20 mg xylazine ip until pain reflexes were suppressed). The transmitter was inserted into the peritoneal sac, and the two ECG electrodes were placed subcutaneously in the region of the right shoulder and left leg to approximate lead II of the Einthoven surface ECG (18).

Telemetric ECG protocols. After a postoperative recovery period of 14 days, the telemetric ECG was first recorded for 1 h at rest during daytime. The mice were then placed in a water-filled tank for 5 min (tank size: 20 x 30 cm width and 15 cm depth, water temperature 34 ± 2°C). During that period, the mice had to swim to keep on the water surface. After this exercise challenge that resulted in submaximal physical exercise (4), the mice were put back in their normal cages. The ECG was continuously recorded 1 h before the swimming exercise, during swimming, and for 1 h after swimming using a custom-written data-acquisition software package based on the LabView programming language. Littermate pairs of mice were simultaneously subjected to the protocol.

In four pairs of mice, pertussis toxin (150 µg/kg body wt) was applied intraperitoneally to block pertussis toxin-sensitive G proteins, which mediate the A1AR signal (28). Thereafter, heart rate was continuously monitored for 72 h or until the death of the animals.

Isolated Heart Measurements

Isolated Langendorff-perfused mouse hearts were studied using previously published techniques (9). In brief, hearts of littermate WT and TG mice were rapidly excised via a median thoracotomy and perfused on a vertical Langendorff apparatus (Hugo Sachs Harvard Apparatus; March-Hugstetten, Germany) using a modified 37°C warm oxygenated Krebs-Henseleit solution containing (in mM) 118 NaCl, 24.88 NaHCO3, 41.2 KH2PO, 5.55 glucose, 2 Na-pyruvate, 0.83 MgSO4, 1.8 CaCl2, and 4.7 KCl. After an initial period of 10 min to allow the preparation to stabilize, the heart was perfused at a constant perfusion pressure of 90–100 mmHg, and the flow rate was measured. Thereafter, perfusion was kept at the previously measured flow rate (4 ± 1 ml/min). An octapolar catheter designed for murine electrophysiological measurements (CI'BER mouse, NuMed) was inserted into the right atrium and right ventricle. Two monophasic action potential catheters were placed onto the epicardium of the right and left atrium, and another one on the left ventricle. Catheters were mounted on a custom-made spring-loaded mechanism to ensure gentle and constant pressure and an orthogonal contact of the catheter tip with the epicardial surface. After placement of the catheters, the preparation was allowed to stabilize for 10 min. Thereafter, the spontaneous rhythm was observed for 5 min. The right atrium was paced at constant heart rates (80- to 140-ms pacing cycle length, corresponding to heart rates of 430–750 beats/min) via the octapolar catheter. At each paced heart rate, pacing was continued for 1.5 min to allow for measurement of steady-state action potential durations. Thereafter, right atrial extrastimulation for determination of effective refractory periods was performed. The pacing protocol was repeated during infusion of orciprenaline (0.74 µM continuous infusion) or adenosine [3 mg bolus (11 µmol) over 5 s, followed by a perfusion of 3 mg/l (11 µM)].

ECG Data Analysis

All analyses were performed blinded to genotype. Surface ECG recordings were manually analyzed for PQ, QRS, and QT intervals and heart rate. Telemetric Holter ECG recordings were analyzed for heart rate and PQ intervals during 5-min periods of normal activity (just before swimming), during the 5-min swimming period, and during the last 5 min of the hour after the end of the swimming exercise. All telemetric recordings were analyzed using a semiautomatic custom-written program for off-line analysis of murine ECG signals based on the LabView programming language. The program automatically determined RR intervals; all computed intervals were verified manually. PQ intervals were analyzed in ECG recordings of matched heart rate. Minimal, mean, and maximal heart rate and heart rate quantiles were calculated for each protocol part. For heart rate variability analysis, the SD of RR intervals was calculated over the entire 2-h telemetric ECG protocol, similar to protocols described by others (11). The entire recording period was manually reviewed for arrhythmias.

The recordings in the isolated hearts were analyzed for atrial heart rate; for the presence of higher-degree AV nodal block; for AV nodal conduction times, measured as the time from the latest atrial activation to the earliest ventricular activation; and for atrial and ventricular action potential duration.

Histology and Protein Biochemistry

The heart was excised after a rapid median thoracotomy. The atria were immersed in formalin and stained using hematoxylin-eosin (H-E) and Sirius red stains. For protein biochemistry, right and left atrial tissue samples were shock frozen and prepared using standard methods (26). For the purpose of this study, we analyzed the protein levels of phospholamban, the {alpha}-subunit of Gi protein (Gi{alpha}), and sarco(endo)plasmatic reticulum Ca2+-ATPase (SERCA; SERCA antibodies were a kind gift of Dr. L. R. Jones; Indianapolis, IN) in the atrial myocardium.

Doppler Echocardiography

Sedated (32 mg/kg body wt ketamine S-13 mg/kg body wt xylazine ip) pairs of TG and WT mice were studied using a Sonos 5500 echocardiography system equipped with a 15-MHz linear transducer and a 12-MHz Doppler transducer (Philips Medical Systems). In addition to conventional echocardiographic parameters, the left atrium was visualized in the parasternal long axis in the plane of the aortic root, and the atrial diameter was measured during early ventricular systole, i.e., at its maximal dimension. Atrial function was assessed using transmitral Doppler flow measurements.

Statistics

All functional analyses (echocardiography, ECG) were performed blinded to genotype. All variables were compared between genotypes by post hoc Student's t-test and ANOVA analyses using Microsoft Excel 2000 and SPSS (version 10) software packages. The incidence of AV nodal block and arrhythmias were compared using Fisher's exact test. Twosided P values <0.05 were considered significant. All values are reported as means ± SE.


    RESULTS
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
ECG Recordings

Surface ECG parameters in sedated animals were not different between TG and WT mice (Table 1). Of note, neither bradycardia nor AV nodal block nor any sign of atrial or ventricular arrhythmia was noted under these experimental conditions. We use the term "bradycardia" in this paper to describe a relative bradycardia of TG mice compared with WT littermates. In our study, WT mice had heart rates comparable to murine heart rates reported by others. Therefore, the term bradycardia also implies that heart rates were lower than those usually observed in mice under the respective experimental conditions. Next, we recorded the ECG in freely moving animals (Fig. 1). Thereby, we could measure the ECG without the influence of anesthetic agents and furthermore assess the effect of exercise on the ECG. During exercise, we expected to observe the so-called "antiadrenergic effect" of A1AR in vivo.


View this table:
[in this window]
[in a new window]
 
Table 1. Surface ECG parameters in sedated WT and TG mice

 


View larger version (27K):
[in this window]
[in a new window]
 
Fig. 1. Telemetric ECG recording from a freely moving wild-type (WT) mouse and an A1 adenosine receptor (A1AR)-overexpressing transgenic (TG) mouse during normal activity (A) and during swimming exercise (B). Heart rate (HR) is lower in the TG mouse at rest and during exercise. The PQ interval is prolonged.

 

Minimal heart rate was not different between WT and TG mice in any of the protocol parts, including exercise. Whereas the mean heart rate was not different during normal activity, it was lower during exercise and 1 h after exercise in TG mice. The maximal heart rate was lower in TG mice during all protocol parts (Fig. 2). Heart rate variability, usually regarded as a measure of the balance of sympathetic and parasympthetic tone in vivo, was reduced by 30% in TG mice (Fig. 3). The difference in the SD of RR intervals was still significant when the value was corrected for mean heart rate (data not shown).



View larger version (24K):
[in this window]
[in a new window]
 
Fig. 2. Decreased chronotropic response to exercise in conscious TG mice. Minimal (Min), mean, and maximal (Max) HRs are given for WT (n = 7) and TG mice (n = 7) during normal activity (A), during exercise (B), and 1 h after exercise (C). *Significant differences between TG and WT mice.

 


View larger version (8K):
[in this window]
[in a new window]
 
Fig. 3. Lower HR variability in conscious TG mice. HR variability, calculated as SD of RR intervals, is given for WT (n = 7) and A1AR-overexpressing TG (n = 7) mice. *Significant differences between TG and WT mice.

 

In contrast to the findings in sedated animals, AV nodal conduction was slower in conscious TG mice (Fig. 4). Of note, AV nodal conduction slowing was present at rest and during exercise.



View larger version (13K):
[in this window]
[in a new window]
 
Fig. 4. Prolonged PQ interval in conscious TG mice. A: mean PQ interval during normal activity and during exercise in WT (n = 7) and TG (n = 7) mice. *Significant differences between TG and WT mice. B: representative recording of a prolonged PQ interval in a freely moving TG mouse during normal activity and a representative WT recording for comparison.

 

Effects of Pertussis Toxin

Pertussis toxin (150 µg/kg body wt) was given intraperitoneally to four pairs of mice to inhibit the function of Gi proteins. This dose was sufficient to block the negative inotropic effects of adenosine and carbachol in isolated left atrial preparations (27, 28). The time course of this effect is shown in Fig. 5. Forty-eight hours after the application of pertussis toxin, bradycardia was completely reversed in freely moving TG mice, whereas protracted AV nodal conduction persisted, albeit in a diminished fashion, compared with WT animals (Fig. 5).



View larger version (18K):
[in this window]
[in a new window]
 
Fig. 5. Pertussis toxin (PTx) reverses bradycardia and attenuates atrioventricular (AV) nodal conduction delay in conscious TG mice. A: mean HR after administration of PTx in TG (n = 4) and WT (n = 4) mice. Maximal HR was also not different 48 h after the application of PTx (data not shown). B: PQ interval after administration of PTx. The PQ interval is less prolonged in TG mice 48 h after the administration of PTx. Mean intervals are given for matched pairs of simultaneously monitored WT (n = 4) and TG (n = 4) mice. *Significant differences from WT. #Significant differences from values before PTx.

 

Atrial and Ventricular Morphology and Function

Atrial conduction abnormalities and atrial arrhythmias could be due to increased size or altered morphology (fibrosis, necrosis) of the atria. To study these possibilities, the subsequent experiments were performed. Atrial weight (Table 2) and atrial size were not different between TG mice and controls (Table 3). Atrial function as assessed by mitral valve Doppler echocardiography was also not different between genotypes (Table 3). The histology of H-E-stained sections of atria from WT and TG hearts exhibited no difference (data not shown). In contrast to A3 adenosine receptor-overexpressing mice (unpublished observations), no fibrosis or necrosis was observed in TG atria (data not shown).


View this table:
[in this window]
[in a new window]
 
Table 2. Gravimetric and atrial biochemical measurements in WT and TG mice

 

View this table:
[in this window]
[in a new window]
 
Table 3. Atrial and ventricular Doppler echocardiographic measurements in WT and TG mice

 

Calcium release from the sarcoplasmatic reticulum is the major determinant of cardiac contraction and an important modulator of pacemaker activity (21). To exclude the possibility that altered sarcoplasmatic Ca2+ handling leads to atrial dysfunction, we measured the expression of important Ca2+-regulatory proteins of the sarcoplasmatic reticulum. Their expression was not different between TG and WT atria (Table 2, right atrial measurements). Protein content was also not different in left atrial samples between genotypes, nor were there differences between the right and left atrial protein content (data not shown).

Electrophysiology in Isolated Hearts

To assess heart rate and AV nodal conduction in the intact heart deprived of autonomic influences, we studied isolated Langendorff-perfused hearts of TG (n = 7) and WT (n = 9) mice during spontaneous rhythm and atrial pacing. Mean spontaneous heart rates were lower in hearts from TG mice than in hearts from WT controls at baseline (Fig. 6). Orciprenaline, a {beta}-adrenoceptor agonist, accelerated the mean heart rate in TG and WT hearts, but heart rate remained lower in TG hearts than in WT hearts (mean heart rate during orciprenaline infusion: TG 479 ± 38 beats/min, n = 7, vs. WT 646 ± 27 beats/min, n = 9, P < 0.05). AV intervals were longer in TG hearts during atrial pacing, consistent with first-degree AV nodal block (Fig. 6). Despite the relative bradycardia, third-degree AV nodal block was present spontaneously (n = 1) or developed during orciprenaline infusion (n = 4) in five of six TG hearts but in zero of nine control hearts (P < 0.01). The addition of adenosine into the perfusate (3 mg over 5 s) caused transient AV nodal block in four of six TG and three of nine WT hearts (P = not significant). In three of six TG hearts, but in zero of nine control hearts, nonsustained episodes of spontaneous atrial tachyarrhythmias were observed at baseline (n = 2; Fig. 6) or after the administration of adenosine (n = 1, P < 0.01).



View larger version (36K):
[in this window]
[in a new window]
 
Fig. 6. Bradycardia, AV block, and atrial tachyarrhythmias in isolated hearts of TG mice. A: recording of right atrial (RA) and left atrial (LA) monophasic action potentials and a tissue bath ECG in a WT heart (left) and in a TG heart (right) during spontaneous rhythm. Although the TG heart is bradycardic, only every second atrial activation is conducted to the ventricle. The recording is reminiscent of dual antegrade AV nodal conduction. B: mean HR in isolated WT and TG hearts at baseline and after the addition of orciprenaline (0.74 µM) to the perfusate. C: mean AV intervals in isolated WT and TG hearts during atrial pacing. The AV interval (ordinate) is plotted versus the pacing cycle length (abscissa) for WT and TG hearts. *Significant differences between TG and WT hearts. D: spontaneous nonsustained episode of atrial tachyarrhythmias in a TG mouse heart. Recordings are labeled as in A.

 

To test whether A1AR overexpression alters cardiac repolarization, we also measured atrial and ventricular action potential durations (9). As expected, atrial action potential duration was shorter than ventricular action potential duration, and action potential duration decreased during pacing at high heart rates (Table 4). Neither atrial nor ventricular action potential durations were altered in isolated hearts from TG mice (Table 4). While unaltered action potential durations cannot rule out compensated changes in repolarizing currents, these data suggest that A1AR overexpression does not alter the time course of repolarization in epicardial working myocardium under basal conditions.


View this table:
[in this window]
[in a new window]
 
Table 4. Epicardial atrial and ventricular steady-state monophasic/A-Ds APD50, APD70, and APD90 during constant atrial pacing at different heart rates in isolated hearts from WT and TG mice

 


    DISCUSSION
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Main Findings

Overexpression of A1AR depresses the physiological chronotropic response to exercise and slows AV nodal conduction in vivo and in the isolated heart. These in vivo effects are observed under conditions of normal endogenous adenosine production (absence of ischemia). Furthermore, isolated hearts developed episodes of spontaneous atrial tachyarrhythmias at baseline or after challenge with adenosine. Taken together, this phenotype closely resembles sinus node dysfunction.

Heart Rate Response to Exercise

Maximal heart rate was lower in TG mice during all protocol parts, suggesting that A1AR activation depresses the response to {beta}-adrenoreceptor activation (the so-called antiadrenergic effect), potentially by decreasing cAMP levels via Gi proteins or by activating phosphatases (12, 13), thereby causing a decreased mean heart rate during and after exercise. In small mammals, similar to our findings, the mean in vivo heart rate is under control of sympathetic activation. Furthermore, parasympathetic stimulation is probably not very active in mouse hearts in vivo, as atropine appears to be without effect on heart rate in freely moving mice (Fig. 5 in Ref. 35). Conceivably, the maximum heart rate occurs during periods of sympathetic stimulation in freely moving animals when, e.g., flight reflexes are activated. During these periods, A1AR activation decreases the heart rate via the antiadrenergic effect discussed above. These considerations can explain the fact that maximal heart rates were lower during normal activity in TG mice. A depressed heart rate increase in response to sympathetic stimulation could also explain the reduced heart rate variability in TG mice without increases in basal sympathetic tone. This is in contrast to patients with heart failure: in these patients, decreased heart rate variability is explained by increased basal sympathetic action and reduced parasympathetic effects. An increased basal sympathetic tone could, however, also be present in TG mice, as mean in vivo heart rates were not different during normal activity (see Resting and Intrinsic Heart Rate).

Consistent with a G protein-dependent postreceptor signaling pathway, treatment with pertussis toxin, an irreversible blocker of G proteins (27, 28), completely abolished the difference in heart rate between TG and WT mice.

Resting and Intrinsic Heart Rate

Heart rate in the isolated heart reflects the intrinsic heart rate (15). The mean intrinsic heart rate was lower in isolated hearts and isolated right atrial preparations from TG mice compared with littermate control mice (13, 23, 27). Minimal heart rates, in contrast, were not different between WT and TG mice in freely moving animals (Fig. 2, left), nor was heart rate different in sedated animals (Table 1). These findings indicate an intrinsic heart rate-lowering action of A1AR even in the absence of catecholaminergic or direct sympathetic nerval stimulation. This effect might be due to amplification of the negative chronotropic effect of endogeneous adenosine by A1AR overexpression or might even be due to tonic activation of steps down-stream of the A1AR due to tense coupling of the nonoccupied ("empty") receptor to subsequent G proteins in the signal transduction cascade, as discussed for the {beta}2-adrenoceptor (25).

AV Nodal Conduction Delay

Overexpression of A1AR caused AV nodal conduction delay in the isolated heart and in vivo, an effect that is comparable to the acute effects of A1AR agonists on AV nodal conduction in healthy human subjects (20). In contrast to the heart rate changes observed, AV nodal conduction was prolonged in freely moving TG mice irrespective of exercise status, and pertussis toxin did not fully reverse AV nodal conduction slowing. The negative dromotropic effect of adenosine has been explained by A1AR activation of the inward rectifier K+ current IK,ACh (also called IK,ADo) and by inhibition of stimulatory {beta}-adrenergic effects on the L-type Ca2+ current. However, adenosine alone causes minimal to no effect on unstimulated, basal L-type Ca2+ current in AV nodal cells, thereby rendering this mechanism unlikely to cause AV nodal conduction delay, at least in isolated (denervated) hearts. Furthermore, the negative dromotropic effect of adenosine is not diminished in vivo in mice lacking IK,ACh (35), so IK,ACh is probably not involved in this pathway. In fact, work in guinea pig and rabbit AV nodal cells indicates that adenosine mediates its negative dromotropic effects at concentrations smaller than 2 µM (which are probably reached in normoxia) rather via activation of a potassium current with delayed rectifying properties [guinea pig AV nodal cells (22)]. Taken together, these findings may suggest that A1AR couple to different ion channels with different efficiency, using different G proteins as signal transductors. Furthermore, enhanced expression of G proteins in the AV node (8) could help to explain the weaker effect of pertussis toxin on AV nodal function than on heart rate in TG mice in vivo.

Atrial Arrhythmias

When challenged with adenosine, hearts from TG mice developed nonsustained atrial arrhythmias. This observation resembles those made in patients with the so-called "tachycardia-bradycardia" variant of sinus node dysfunction. The mechanisms resulting in atrial tachyarrhythmias in TG hearts remain to be elucidated. Some data on the effect of bradycardia and adenosine on spontaneous depolarizations allow us, however, to suggest a hypothetical mechanism by which A1AR overexpression could result in atrial tachyarrhythmias: administration of exogeneous adenosine activates K+ channels via A1AR, thereby contributing to afterdepolarizations and triggered activity (3, 30, 36). Furthermore, bradycardia in itself can facilitate afterdepolarizations that cause tachycardias in a model of the long QT syndrome (10). Similarly, afterdepolarizations may have initiated episodes of atrial tachyarrhythmias in TG hearts in the present study. In addition, adenosine-induced atrial arrhythmias could also be maintained by activation of IK,ACh: inactivation of IK,ACh by functional deletion of one of its two constituent proteins (GIRK4) reduces inducibility of atrial arrhythmias in mice (17). Activation of IK,ACh by A1AR overexpression, in contrast, may decrease the threshold of atrial tachyarrhythmias. Further studies are needed to verify these potential mechanisms of tachyarryhthmia induction in TG hearts. Of note, we found no histological alterations (necrosis or fibrosis) that could explain the electrophysiological observations we report here.

Implications

Our data support the concept that the negative chronotropic effects of adenosine during periods of enhanced catecholaminergic stimulation and the negative dromotropic effects of adenosine are mediated by A1AR. Altered activity of A1AR could contribute to the differences in intrinsic heart rate recorded in vivo in the presence of atropine and {beta}-adrenoreceptor blockers (1, 15, 16). Further studies may determine whether these findings in a mouse model with high-level overexpression of A1AR can be reproduced in conditions that are closer to human physiology.

Genetic causes for sinus node dysfunction have only been identified in a small proportion of affected patients. Although our observations have been made in TG mice, and not in humans, the search for genetic causes of bradycardia and AV nodal block may be extended to alterations in the A1AR gene, especially when a decreased chronotropic response to exercise is coupled with AV nodal conduction delay or paroxysmal atrial tachyarrhythmias.

During ischemia, adenosine levels are regionally and markedly increased in the heart (2, 5, 23, 29), resulting in an increased activation of adenosine receptors. Our findings support the concept that activation of adenosine receptors could cause reversible bradycardia and AV nodal block in patients with acute inferior myocardial infarction (33). Insufficient perfusion of the sinus nodal area could also chronically elevate adenosine levels and thereby contribute to chronic sinus nodal and AV nodal dysfunction (33, 34).


    FOOTNOTES
 

Address for reprint requests and other correspondence: P. Kirchhof, Medizinische Klinik C, Kardiologie und Angiologie, Universitätsklinikum Münster, Albert-Schweitzer-Strasse 33, D-48129 Münster, Germany (E-mail: kirchhp{at}uni-muenster.de).

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

* P. Kirchhof and L. Fabritz contributed equally to this study. Back


    REFERENCES
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Alboni P, Malcarne C, Pedroni P, Masoni A, and Narula OS. Electrophysiology of normal sinus node with and without autonomic blockade. Circulation 65: 1236-1242, 1982.[Free Full Text]
  2. Bardenheuer H and Schrader J. Supply-to-demand ratio for oxygen determines formation of adenosine by the heart. Am J Physiol Heart Circ Physiol 250: H173-H180, 1986.[Abstract/Free Full Text]
  3. Belardinelli L, Shryock JC, Song Y, Wang D, and Srinivas M. Ionic basis of the electrophysiological actions of adenosine on cardiomyocytes. FASEB J 9: 359-365, 1995.[Abstract/Free Full Text]
  4. Cogliati T, Good DJ, Haigney M, Delgado-Romero P, Eckhaus MA, Koch WJ, and Kirsch IR. Predisposition to arrhythmia and autonomic dysfunction in Nhlh1-deficient mice. Mol Cell Biol 22: 4977-4983, 2002.[Abstract/Free Full Text]
  5. Deussen A. Metabolic flux rates of adenosine in the heart. Naunyn Schmiedebergs Arch Pharmacol 362: 351-363, 2000.[ISI][Medline]
  6. DiFrancesco D. The onset and autonomic regulation of cardiac pacemaker activity: relevance of the f current. Cardiovasc Res 29: 449-456, 1995.[ISI][Medline]
  7. DiMarco J, Sellers TD, Berne RM, West GA, and Belarrdinelli L. Adenosine: electrophysiologic effects and therapeutic use for terminating paroxysmal supraventricular tachycardia. Circulation 68: 1254-1263, 1983.[Abstract/Free Full Text]
  8. Eschenhagen T, Laufs U, Schmitz W, Scholz H, Warnholtz A, Weil J, and Schafer HJ. Enrichment of G protein alpha-subunit mRNAS in the AV-conducting system of the mammalian heart. J Mol Cell Cardiol 27: 2249-2263, 1995.[ISI][Medline]
  9. Fabritz L, Kirchhof P, Franz MR, Eckardt L, Mönnig G, Milberg P, Breithardt G, and Haverkamp W. Prolonged action potential durations, increased dispersion of repolarization, and polymorphic ventricular tachycardia in a mouse model of proarrhythmia. Basic Res Cardiol 98: 25-32, 2003.[ISI][Medline]
  10. Fabritz L, Kirchhof P, Franz MR, Nuyens D, Rossenbacker T, Ottenhof A, Haverkamp W, Breithardt G, Carmeliet E, and Carmeliet P. Effect of pacing and mexiletine on dispersion of repolarisation and arrhythmias in hearts of SCN5A {partial}-KPQ (LQT3) mice. Cardiovasc Res 57: 1085-1093, 2003.[Abstract/Free Full Text]
  11. Gehrmann J, Hammer PE, Maguire CT, Wakimoto H, Triedman JK, and Berul CI. Phenotypic screening for heart rate variability in the mouse. Am J Physiol Heart Circ Physiol 279: H733-H740, 2000.[Abstract/Free Full Text]
  12. Gupta RC, Neumann J, Durant P, and Watanabe AM. A1-adenosine receptor-mediated inhibition of isoproterenol-stimulated protein phosphorylation in ventricular myocytes. Evidence against a cAMP-dependent effect. Circ Res 72: 65-74, 1993.[Abstract/Free Full Text]
  13. Headrick JP, Gauthier NS, Morrison RR, and Matherne GP. Chronotropic and vasodilatory responses to adenosine and isoproterenol in mouse heart: effects of adenosine A1 receptor overexpression. Clin Exp Pharmacol Physiol 27: 185-190, 2000.[ISI][Medline]
  14. Huang C, Slesinger P, Casey P, Jan Y, and Jan L. Evidence that direct binding of G beta gamma to the GIRK1 G proteingated inwardly rectifying K+ channel is important for channel activation. Neuron 15: 1133-1143, 1995.[ISI][Medline]
  15. Jose AD and Collison D. The normal range and determinants of the intrinsic heart rate in man. Cardiovasc Res 4: 160-167, 1970.[Abstract/Free Full Text]
  16. Jose AD, Stitt F, and Collison D. The effects of exercise and changes in body temperature on the intrinsic heart rate in man. Am Heart J 79: 488-498, 1970.[ISI][Medline]
  17. Kovoor P, Wickman K, Maguire CT, Pu W, Gehrmann J, Berul CI, and Clapham DE. Evaluation of the role of IKACh in atrial fibrillation using a mouse knockout model. J Am Coll Cardiol 37: 2136-2143, 2001.[Abstract/Free Full Text]
  18. Kramer K, van Acker SA, Voss HP, Grimbergen JA, van der Vijgh WJ, and Bast A. Use of telemetry to record electrocardiogram and heart rate in freely moving mice. J Pharmacol Toxicol Methods 30: 209-215, 1993.[ISI][Medline]
  19. Lehmann H and Klein UE. Familial sinus node dysfunction with autosomal dominant inheritance. Br Heart J 40: 1314-1316, 1978.[Abstract/Free Full Text]
  20. Lerman BB, Ellenbogen KA, Kadish A, Platia E, Stein KM, Markowitz SM, Mittal S, Slotwiner DJ, Scheiner M, Iwai S, Belardinelli L, Jerling M, Shreeniwas R, and Wolff AA. Electrophysiologic effects of a novel selective adenosine A1 agonist (CVT-510) on atrioventricular nodal conduction in humans. J Cardiovasc Pharmacol 6: 237-245, 2001.
  21. Marks AR. Ryanodine receptors/calcium release channels in heart failure and sudden cardiac death. J Mol Cell Cardiol 33: 615-624, 2001.[ISI][Medline]
  22. Martynyuk AE, Seubert CN, Zima A, Morey TE, Belardinelli L, Lin G, Cucchiara RF, and Dennis DM. Contribution of IK,ADO to the negative dromotropic effect of adenosine. Basic Res Cardiol 97: 286-294, 2002.[ISI][Medline]
  23. Matherne GP, Linden J, Byford AM, Gauthier NS, and Headrick JP. Transgenic A1 adenosine receptor overexpression increases myocardial resistance to ischemia. Proc Natl Acad Sci USA 94: 6541-6546, 1997.[Abstract/Free Full Text]
  24. Mehta AV, Chidambaram B, and Garrett A. Familial symptomatic sinus bradycardia: autosomal dominant inheritance. Pediatr Cardiol 16: 231-234, 1995.[ISI][Medline]
  25. Milano C, Allen L, Rockman HA, Dolber PC, McMinn T, Chien K, Johnson T, Bond R, and Lefkowitz R. Enhanced myocardial function in transgenic mice overexpressing the beta 2-adrenergic receptor. Science 264: 582-586, 1994.[Abstract/Free Full Text]
  26. Neumann J, Boknik P, DePaoli-Roach A, Field L, Rockman H, Kobayashi Y, Kelley J, and Jones L. Targeted overexpression of phospholamban to mouse atrium depresses Ca2+ transport and contractility. J Mol Cell Cardiol 30: 1991-2002, 1998.[ISI][Medline]
  27. Neumann J, Boknik P, Matherne GP, Lankford AR, and Schmitz W. Pertussis toxin sensitive and insensitive effects of adenosine and carbachol in murine atria overexpressing A1-adenosine receptors. Br J Pharmacol. In press.
  28. Neumann J, Vahlensieck U, Boknik P, Linck B, Luss H, Muller FU, Matherne GP, and Schmitz W. Functional studies in atrium overexpressing A1-adenosine receptors. Br J Pharmacol 128: 1623-1629, 1999.[ISI][Medline]
  29. Shryock JC and Belardinelli L. Adenosine and adenosine receptors in the cardiovascular system: biochemistry, physiology, and pharmacology. Am J Cardiol 79: 2-10, 1997.[ISI][Medline]
  30. Song Y, Wu L, Shryock JC, and Belardinelli L. Selective attenuation of isoproterenol-stimulated arrhythmic activity by a partial agonist of adenosine A1 receptor. Circulation 105: 118-123, 2002.[Abstract/Free Full Text]
  31. Tchou PJ and Chung MK. Sick sinus syndrome and hypersensitive carotid sinuns syndrome. In: Cardiac Electrophysiology: From Cell to Bedside, edited by Zipes DP and Jalife J. Philadelphia, PA: Saunders, 2000, p. 862-873.
  32. Wainger BJ, DeGennaro M, Santoro B, Siegelbaum SA, and Tibbs GR. Molecular mechanism of cAMP modulation of HCN pacemaker channels. Nature 411: 805-810, 2001.[Medline]
  33. Wesley R Jr, Lerman BB, DiMarco JP, Berne RM, and Belardinelli L. Mechanism of atropine-resistant atrioventricular block during inferior myocardial infarction: possible role of adenosine. J Am Coll Cardiol 8: 1232-1234, 1986.[Abstract]
  34. Wesley RC Jr, Boykin MT, and Belardinelli L. Role of adenosine as mediator of bradyarrhythmias during hypoxia in isolated guinea pig hearts. Cardiovasc Res 20: 752-759, 1986.[ISI][Medline]
  35. Wickman K, Nemec J, Gendler SJ, and Clapham DE. Abnormal heart rate regulation in GIRK4 knockout mice. Neuron 20: 103-114, 1998.[ISI][Medline]
  36. Wu L, Belardinelli L, Zablocki JA, Palle V, and Shryock JC. A partial agonist of the A1-adenosine receptor selectively slows AV conduction in guinea pig hearts. Am J Physiol Heart Circ Physiol 280: H334-H343, 2001.[Abstract/Free Full Text]
  37. Xue T, Marban E, and Li RA. Dominant-negative suppression of HCN1- and HCN2-encoded pacemaker currents by an engineered HCN1 construct: insights into structure-function relationships and multimerization. Circ Res 90: 1267-1273, 2002.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
Physiol. Rev.Home page
M. E. Mangoni and J. Nargeot
Genesis and Regulation of the Heart Automaticity
Physiol Rev, July 1, 2008; 88(3): 919 - 982.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
J. M. Lignon, Z. Bichler, B. Hivert, F. E. Gannier, P. Cosnay, J. A. del Rio, D. Migliore-Samour, and C. O. Malecot
Altered heart rate control in transgenic mice carrying the KCNJ6 gene of the human chromosome 21
Physiol Genomics, April 21, 2008; 33(2): 230 - 239.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Knaus, X. Zong, N. Beetz, R. Jahns, M. J. Lohse, M. Biel, and L. Hein
Direct Inhibition of Cardiac Hyperpolarization-Activated Cyclic Nucleotide-Gated Pacemaker Channels by Clonidine
Circulation, February 20, 2007; 115(7): 872 - 880.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H. Funakoshi, T. O. Chan, J. C. Good, J. R. Libonati, J. Piuhola, X. Chen, S. M. MacDonnell, L. L. Lee, D. E. Herrmann, J. Zhang, et al.
Regulated Overexpression of the A1-Adenosine Receptor in Mice Results in Adverse but Reversible Changes in Cardiac Morphology and Function
Circulation, November 21, 2006; 114(21): 2240 - 2250.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. M. Marin and K. G. Franchini
Reduced oxygen supply explains the negative force-frequency relation and the positive inotropic effect of adenosine in buffer-perfused hearts
Am J Physiol Heart Circ Physiol, July 1, 2005; 289(1): H131 - H136.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
U. Kirchhefer, H. A. Baba, G. Hanske, L. R. Jones, P. Kirchhof, W. Schmitz, and J. Neumann
Age-dependent biochemical and contractile properties in atrium of transgenic mice overexpressing junctin
Am J Physiol Heart Circ Physiol, November 1, 2004; 287(5): H2216 - H2225.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
285/1/H145    most recent
01036.2002v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (16)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kirchhof, P.
Right arrow Articles by Boknik, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kirchhof, P.
Right arrow Articles by Boknik, P.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2003 by the American Physiological Society.